Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Diseases

Free Subscription 06.04.2026 1 Am J Gastroenterol 4 Anticancer Res 3 BMC Cancer 1 BMC Gastroenterol 1 Cancer Res 5 Eur Radiol 2 Gastroenterology 2 Gastrointest Endosc 2 Gut 2 Hepatology 1 Indian J Gastroenterol 2 J Gastroenterol 1 J Gastroenterol Hepatol 3 J Hepatol 1 N Engl J Med 2 Oncogene 5 PLoS One 1 Radiol Imaging Cancer 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. LEE D, Maravic Z, Moon AM, Langenbacher D, et al
   Enhancing Patient Empowerment Through Artificial Intelligence in Liver Cancer.
   Am J Gastroenterol. 2026;121:847-854.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. KATAYAMA R, Aoki T, Tashiro Y, Hirai T, et al
   Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases.
   Anticancer Res. 2026;46:2087-2093.
   PubMed         Abstract available
   
   
3. SHIMOHIGASHI Y, Toya R, Kai Y, Doi Y, et al
   Whole-liver Palliative Radiotherapy Using SIB for Diffuse Liver Metastases: 3D-CRT versus (99m)Tc-GSA SPECT Image-guided VMAT.
   Anticancer Res. 2026;46:2277-2284.
   PubMed         Abstract available
   
   
4. HOSHIAI S, Yamada T, Kobayashi M, Amano T, et al
   Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial.
   Anticancer Res. 2026;46:2053-2062.
   PubMed         Abstract available
   
   
5. ZHOU Y, Nakamura M, Makita K, Hiroshima Y, et al
   Clinical Outcomes of Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract.
   Anticancer Res. 2026;46:2175-2185.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. JIANG HH, Feng GY, Shi Y, Li XD, et al
   Chemoresistance and genetic mutations in hepatocellular carcinoma: a pharmacogenomic atlas of 51 patients.
   BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15621.
   PubMed        
   
   
7. ZHAO YM, Xie SS, Yu YQ, Li ZX, et al
   A web-based prognostic nomogram incorporating VETC-associated imaging markers for predicting postoperative recurrence in hepatocellular carcinoma.
   BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15895.
   PubMed        
   
   
8. WANG X, Jiang Q, Chen S, Li Y, et al
   Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study.
   BMC Cancer. 2026 Apr 1. doi: 10.1186/s12885-026-15930.
   PubMed        
   
   

   
   BMC Gastroenterol

9. IBRAHIM A, Abdelhady SA, Rageh F, Elgamal R, et al
   Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma.
   BMC Gastroenterol. 2026 Apr 2. doi: 10.1186/s12876-026-04740.
   PubMed        
   
   

   
   Cancer Res

10. GREENE E, Horvat NK, Doxie DB, Parihar VC, et al
    High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.
    Cancer Res. 2026;86:1753-1768.
    PubMed         Abstract available
    
    

    
    Eur Radiol

11. WANG D, Lyu R, Zhang Y, Hu WJ, et al
    LI-RADS nonradiation treatment response assessment version 2024: diagnostic performance in HCC treated with transarterial chemoembolization.
    Eur Radiol. 2026;36:2823-2831.
    PubMed         Abstract available
    
    
12. PAISANT A, Roux M, Calame P, Lecharpentier A, et al
    Liver viscosity: pathological significance and interest for the assessment of MASLD severity in clinical practice.
    Eur Radiol. 2026;36:2978-2988.
    PubMed         Abstract available
    
    
13. ZHANG L, Wang L, Zhang Y, Zhang X, et al
    Fully automated multi-sequence detection and alignment of focal liver lesions in dynamic contrast-enhanced MRI.
    Eur Radiol. 2026;36:2435-2445.
    PubMed         Abstract available
    
    
14. OZAKI K, Ohtani T, Ishida S, Higuchi S, et al
    Predicting histopathological growth patterns and prognosis of colorectal liver metastases using MRI.
    Eur Radiol. 2026;36:2912-2928.
    PubMed         Abstract available
    
    
15. JEONG B, Han DH, Lee S, Yoon JK, et al
    Diagnosing HCC with conventional and late portal venous phase MRI: intraindividual comparison of MRI with extracellular contrast agent.
    Eur Radiol. 2026;36:2903-2911.
    PubMed         Abstract available
    
    

    
    Gastroenterology

16. BALAJI S, Bhat M
    Building the Human Liver in a Dish: Organoids, Assembloids and the Road to Precision Hepatology.
    Gastroenterology. 2026 Apr 1:S0016-5085(26)00310.
    PubMed        
    
    
17. SCARALLO L, Alvisi P, Bramuzzo M, Domanico A, et al
    Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN.
    Gastroenterology. 2026 Mar 16:S0016-5085(26)00232.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

18. LI J, Wang Y, Zhou Y, Wang J, et al
    Endoscopic ultrasound mapping of the gastroepiploic vein in sinistral portal hypertension.
    Gastrointest Endosc. 2026 Apr 1:S0016-5107(26)00231.
    PubMed        
    
    
19. BUTT MA, Mirminachi B, Cifuentes L, Hwang JH, et al
    Outcomes of Peroral Endoscopic Myotomy in Patients With Cirrhosis: A Multicenter Focused Communication.
    Gastrointest Endosc. 2026 Mar 26:S0016-5107(26)00217.
    PubMed         Abstract available
    
    

    
    Gut

20. CHEN Y, Dong B, Jin X, Liu C, et al
    Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.
    Gut. 2026;75:576-587.
    PubMed         Abstract available
    
    
21. JIAO J, Song L, Xu S, Xue Y, et al
    Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment.
    Gut. 2026 Apr 1:gutjnl-2025-336422. doi: 10.1136/gutjnl-2025-336422.
    PubMed         Abstract available
    
    

    
    Hepatology

22. SANYAL AJ, Abdelmalek MF, Loomba R
    Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH).
    Hepatology. 2026 Mar 30. doi: 10.1097/HEP.0000000000001734.
    PubMed         Abstract available
    
    
23. PILAR BALLESTER M, Carbonell-Asins JA, Elshabrawi A, Rubin D, et al
    A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.
    Hepatology. 2026 Apr 3. doi: 10.1097/HEP.0000000000001748.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

24. KUMAR K, Vaithiyam V, Sonika U, Srivastava S, et al
    Bleeding ectopic varices at hepaticojejunostomy.
    Indian J Gastroenterol. 2026 Mar 28. doi: 10.1007/s12664-026-01997.
    PubMed        
    
    

    
    J Gastroenterol

25. KUMADA T, Toyoda H, Ogawa S, Gotoh T, et al
    Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach.
    J Gastroenterol. 2026 Apr 2. doi: 10.1007/s00535-026-02403.
    PubMed         Abstract available
    
    
26. REN X, Yan C, Liu X, Jia X, et al
    Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae.
    J Gastroenterol. 2026;61:462-476.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

27. JINATO T, Sikaroodia M, Gilleveta PM, Dissayabutra T, et al
    Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort.
    J Gastroenterol Hepatol. 2026 Mar 30. doi: 10.1111/jgh.70358.
    PubMed         Abstract available
    
    

    
    J Hepatol

28. ZENG J, Gao Z, Jiang Y, Dai Z, et al
    Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China.
    J Hepatol. 2026 Mar 26:S0168-8278(26)00153-4. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
29. LI S, Tong G, Xue M, Shen L, et al
    Activated hepatic stellate cells maintain liver bile acid homeostasis through paracrine FGF10/FGFR2 signaling.
    J Hepatol. 2026 Mar 26:S0168-8278(26)00149-2. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
30. ZEEVI TT, Mezzacappa CC
    Artificial intelligence uncovers latent signals of portal hypertension in routine CT imaging.
    J Hepatol. 2026 Apr 1:S0168-8278(26)00187-X. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    N Engl J Med

31. KUMAR T, Noda SM
    Hepatic Arterial Buffer Response.
    N Engl J Med. 2026;394:1325.
    PubMed        
    
    

    
    Oncogene

32. WANG M, Hong G, Zhang C, Xiao Y, et al
    CAPRIN1-mediated sequestration of NCOA4 mRNA into stress granules drives sorafenib resistance in hepatocellular carcinoma.
    Oncogene. 2026 Mar 28. doi: 10.1038/s41388-026-03750.
    PubMed         Abstract available
    
    
33. XU S, Gong R, Liu S, Wang J, et al
    Dual function of DOT1L suppresses tumor cell-intrinsic immunogenicity in hepatocellular carcinoma.
    Oncogene. 2026 Mar 31. doi: 10.1038/s41388-026-03744.
    PubMed         Abstract available
    
    

    
    PLoS One

34. DO TX, Nguyen HT, Nguyen PTL, Kieu MTT, et al
    Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.
    PLoS One. 2026;21:e0345212.
    PubMed         Abstract available
    
    
35. TAKAGI A, Fujita A, Tokuda S, Tamura S, et al
    The ability of branched-chain amino acid-to-tyrosine ratio (BTR) to assess preoperative liver function of patients with hepatocellular carcinoma.
    PLoS One. 2026;21:e0344938.
    PubMed         Abstract available
    
    
36. NATURINDA K, Biraro IA, Mupere E, Muyunga A, et al
    Prevalence, perceptions and factors associated with non-adherence to hepatotoxicity monitoring among people living with HIV on tuberculosis preventive treatment at Mulago ISS clinic.
    PLoS One. 2026;21:e0345662.
    PubMed         Abstract available
    
    
37. BIBI A, Afandi MH, Mehmood A, Ashfaq UA, et al
    Anti-hepatocellular carcinoma activity of Jacaranda mimosifolia through experimental validation and network pharmacology.
    PLoS One. 2026;21:e0346325.
    PubMed         Abstract available
    
    
38. ZHANG X, Xu Z, You Y, Xie L, et al
    Lactobacillus casei culture supernatant ameliorates acute alcohol-induced liver injury by inhibiting cellular stress and promoting intestinal integrity in mice.
    PLoS One. 2026;21:e0344960.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

39. JUNG YJ, Kim S, Song IH, Shim JH, et al
    Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250645.
    PubMed         Abstract available
    
    

    
    Radiology

40. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
    Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
    Radiology. 2026;318:e252892.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum